Cell-type-specific innate immune response to oncolytic Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2012-07-18 / Viral Immunol. 2012 Aug;25(4):268-76Bugs and drugs: oncolytic virotherapy in combination with chemotherapy
/in International Publications, Newcastle Disease Virus /von 2012-07-01 / Curr Pharm Biotechnol 2012 Jul;13(9):1817-33Recent clinical experience with oncolytic viruses
/in International Publications, Newcastle Disease Virus /von 2012-07-01 / Curr Pharm Biotechnol 2012 Jul;13(9):1834-41Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization
/in International Publications, Newcastle Disease Virus /von 2012-05-29 / Appl. Biochem. Biotechnol. 2012 Aug;167(7):2005-22Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors
/in International Publications, Newcastle Disease Virus /von 2012-04-18 / Hum. Gene Ther. 2012 Jul;23(7):700-10Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2012-03-08 / Arch. Virol. 2012 Jun;157(6):1011-8Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
/in International Publications, Newcastle Disease Virus /von 2012-03-01 / Future Microbiol 2012 Mar;7(3):347-67Virotherapy of neuroendocrine tumors
/in International Publications, Newcastle Disease Virus /von 2012-02-29 / Neuroendocrinology 2013;97(1):26-34Targeting pediatric cancer stem cells with oncolytic virotherapy
/in International Publications, Newcastle Disease Virus /von 2012-02-15 / Pediatr. Res. 2012 Apr;71(4 Pt 2):500-10
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de